Archive

Baidu Turns Bearish as Q4 Earnings Decline 80% y-o-y

  Loss of revenue from healthcare ads continue to haunt Chinese search engine provider Baidu Inc (NASDAQ: BIDU) which posted nearly 82% decline in the fiscal 2016 fourth-quarter earnings, compared to the corresponding quarter last year. The Q4 revenue also

Read More

GoPro Turns Bullish on Impressive 1Q17 Rev. Outlook

  Earlier this month, action camera manufacturer Gopro Inc (NASDAQ: GPRO) reported fiscal 2016 fourth-quarter earnings that exceeded analysts’ estimates. However, the stock has lost more than 10% so far and closed at $9.66 on Monday. Lower than anticipated fourth-quarter

Read More

Greenback Up on Strong Housing, Low Jobless Claim Data

  Higher than expected inflation rate in January and Q4 GDP growth of 2.9% (versus estimates of 1.8%) strengthened the Singapore dollar against the Greenback in mid-February. Lack of sufficient hawkishness at the US Fed also acted as a catalyst

Read More

Fiat Misses Q4 EPS Estimates, Faces EPA Investigation

  Despite posting an increase in the fiscal 2016 fourth-quarter revenue, compared with last year, the stock of automaker Fiat Chrysler Automobiles N.V. (NYSE: FCAU) has so far appreciated only by about 5% to $11.38. One of the reasons for

Read More

Pound Weakens as EU Prioritises Exit Bill Negotiations

  Considering the weak lending data announced by the Bank of England and soft retail spending in December, we had recommended taking a short position at 142.50 levels in the GBPJPY pair on February 1st, with a target price of

Read More

Rio Tinto Swings to Profit in FY16, Beats Earnings View

  In the second week of February, mining giant Rio Tinto Plc (NYSE: RIO) reported a decline in the fiscal 2016 revenue, compared with last year. However, the stock hit a 12-month high of $47.11. The main reason for the

Read More

Novartis Misses Q4 Rev. View, Issues Flat FY17 Outlook

  Since reporting fiscal 2016 fourth-quarter earnings that beat analysts’ estimates, the stock of Pharmaceutical company Novartis Ag (NYSE: NVS) has risen by 5% to $77.20 (as of Monday). Ironically, the company’s Q4 revenue was below analysts’ expectations. Analysts attribute

Read More

Greenback Strengthens on Strong Building Permit Data

  Soft wage growth, marginally higher-than-anticipated unemployment rate, and decline in the UoM (University of Michigan) consumer sentiment reading (preliminary) weakened the US dollar against the Russian Ruble in early February. The USDRUB pair’s downtrend was also aided by a

Read More

Teva Beats 4Q16 Estimates, Reaffirms FY17 EPS View

  World’s largest generic drug manufacturer Teva Pharmaceutical Industries Ltd (NYSE: TEVA) had missed its own earning guidance in the second and third-quarter of fiscal 2016. This had kept investors on edge during the latest quarter. Fortunately, on Monday, the

Read More

Yen Signals Weakness on Soft Preliminary GDP Growth

  The news of an increase in support for the anti-EU leader Marine Le Pen in the latest French election survey heightened concerns of political uncertainty in the EU. This encouraged speculators to go short in the Euro dollar, while

Read More